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Concise Communication

Utilization of the Sharing Antimicrobial Reports for Pediatric
Stewardship (SHARPS) Collaborative electronic mailing list (listserv)
by healthcare professionals
Christopher C. McPherson PharmD1,2

, Zachary A. Vesoulis MD1, Talene A. Metjian PharmD3, Mirela Grabic1,

Summer Reyes1, Sydney Reyes1, Christina Krucylak1, Cindy Terrill1 and Jason G. Newland MD1
1
Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri, 2Department of Pharmacy, St. Louis Children’s Hospital, St Louis,
Missouri and 3Antimicrobial Stewardship Program, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania

Abstract
Optimizing pediatric antimicrobial stewardship is challenging. In this retrospective study, we evaluated 515 original e-mails to 482 members of
the Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS) Collaborative electronic mailing list (idlistserv@kids.wustl.edu). The
plurality of threads discussed clinical practice guidelines, and pharmacists were most likely to initiate and respond. Representation was geographically diverse within and outside the United States.
(Received 6 August 2020; accepted 22 November 2020)

The need for established antimicrobial stewardship programs
(ASP) in acute-care hospitals has been recognized nationally.1,2
The ASP team members are essential in developing and implementing effective interventions within the framework set forth
by the Centers for Disease Control and Prevention (CDC) and professional societies. In recent years, ASPs serving hospitalized children have rapidly emerged, increasing in both prevalence and
resources.3 In specialty care areas like pediatrics, challenges exist
in defining the most effective antimicrobial stewardship strategies.
In these areas, the learning curve in clinical practice is steep due to
limited exposure to this population in didactic training.4,5
Bridging the gap requires collaborative learning and networking to optimize patient care through the utilization of all available
knowledge. One approach is the use of electronic mailing lists, or
listservs, which have been effectively established by nurses and
occupational therapists to improve the care of pediatric patients.6,7
In 2012, the Sharing Antimicrobial Reports for Pediatric
Stewardship (SHARPS) Collaborative listserv was established for
practitioners specializing in pediatric antimicrobial stewardship.
In this study, we evaluated listserv emails to characterize membership, activity, and subject matter.

members from >70 hospitals that participate in the SHARPS
Collaborative. Other individuals interested in pediatric antimicrobial stewardship and antibiotic use can participate in the listserv
and do not have to be from a SHARPS Collaborative hospital.
Additionally, no individual prerequisites or fees are required to
join the listserv, and participants can unsubscribe at any time.
The listserv functions by individuals submitting a question or
information to a common e-mail address. Each e-mail contains
1 question or information that is then sent to the listserv members.
Responses to individual e-mails are then collated into a single
e-mail thread and re-sent to the listserv members.
In this study, our primary goal was to describe the type of information being shared on the listserv. To do this, the study team
reviewed 50 e-mail threads to define the categories of topics discussed on the listserv. These categories capture broad concepts
of antimicrobial stewardship functionality, clinical practice, and
patient care (Table 1). The remaining e-mails were then coded
by 2 of the authors (S.R. and S.R.). Demographic attributes of
the listserv participants that submitted and responded to the questions were collected; they included medical degree (Table 2) and
academic or hospital affiliation.

Methods

Results

In this retrospective study, we evaluated all e-mails exchanged on
the SHARPS listserv (idlistserv@kids.wustl.edu) from June 16,
2016, to September 30, 2019. The listserv comprises representative

The listserv grew from 220 members in 2016 to 482 by the end of
the study period. In total, 515 original questions or informational
e-mails were sent during the study period (Supplemental Fig. 1
online). For every post, a median of 3 responses were received
(interquartile range, 2–5; range, 0–27); only 16 e-mails received
no responses (3%). The plurality of e-mail threads discussed clinical practice guidelines (Table 1). These discussions included the
sharing of clinical guidelines across institutions and implementation strategies for existing or new clinical practice guidelines in
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Table 1. Categories and Number of Responses for Each E-mail Thread
No. of
Threads (%)

No. of Responses,
Median, (IQR)

Clinical practice guidelines

182 (35)

3 (2–5)

Antimicrobial stewardship
activities

71 (14)

3 (2–5)

Medication dosing

65 (13)

3 (2–6)

Category

Drug delivery

46 (9)

3 (2–4)

Electronic medical record

28 (5)

3 (1–5)

Patient care

24 (5)

3 (1–4)

Laboratory

24 (5)

4 (3–6)

Formulary management

23 (5)

4 (2–9)

Antimicrobial stewardship
infrastructure

16 (3)

2 (0–3)

Shortages

11 (2)

6 (3–12)

Emerging literature

8 (2)

1 (0–1)

Career

3 (1)

5 (1–14)

Outbreaks

3 (1)

6 (4–7)

Regulatory

3 (1)

0 (0–2)

Continuing education

3 (1)

3 (0–20)

3 (1)

1 (0–2)

2 (<1)

N/A

Other
Infection control
Note. IQR, interquartile range.

Table 2. Medical Degrees of Initiators and Respondents of E-mail
Threads
Degree

No. (%)

Initial post
Pharmacist

321 (62)

Physician

176 (34)

Master of public health

40 (8)

Doctor of philosophy

10 (2)

Student

1 (<1)

Response
Pharmacist
Physician
Master of public health

1,366 (64)
629 (30)
128 (6)

Doctor of philosophy

24 (1)

Student

6 (<1)

their hospitals. Clinical guidelines focused on a wide variety of disease states and individual drugs, including neonatal sepsis, pediatric sepsis, pediatric pneumonia, and cystic fibrosis among the most
commonly discussed disease states and vancomycin as the most
commonly discussed drug. Additional categories discussed in
>10% of threads included antimicrobial stewardship activities
and medication dosing. The lack of definitive pharmacokinetic
studies and dosing standards for antimicrobial agents in pediatric
patients was highlighted by the frequent utilization of this listserv
to poll colleagues. The most frequently discussed agents were vancomycin and gentamicin. Finally, while antimicrobial shortages

were discussed in only 2% of the original e-mails, these e-mails
consistently had many more responses than those in more commonly submitted categories.
E-mails originated from diverse geographic regions within the
United States (Supplemental Fig. 2 online). E-mails also originated
from outside the United States, with contributors from Canada, the
United Kingdom, South Africa, and Denmark. Table 2 characterizes the type of healthcare professionals who initiated an e-mail
thread and those who responded.
Discussion
The SHARPS Collaborative listserv is an active tool utilized by healthcare practitioners to gather, exchange, and disseminate information.
The rapid growth and diverse geographic representation highlight the
importance of this forum in both individual patient care and health
system management. This study highlights the potential utility of dialogue and education between pediatric specialists practicing at different centers in a variety of healthcare disciplines.
The diversity of topic categories generating dialogue on the listserv reflects the complexity and variety of challenges within pediatric antimicrobial stewardship. Previous literature has noted a
correlation between listserv topics and trending challenges pertinent to clinical practice.6 Frequently, threads discussed local and
national clinical practice guidelines; however, a review of these
threads reveals the ongoing challenge of translating relatively
robust evidence in adults to pediatric patients. For example, discussion of perioperative antimicrobial prophylaxis following cardiac
surgery prompted circulation of practice guidelines from 8 large
pediatric hospitals, suggesting the urgent need for national standardization. The issue of incomplete evidence and guidance in pediatric patients also drove frequent dialogue around medication
dosing and drug delivery. In medically complex pediatric patients,
well more than half of medication prescriptions remain off label,
with nearly every patient exposed to at least 1 off-label therapy.8,9
Initiatives including the Best Pharmaceuticals for Children Act and
the Pediatric Research Equity Act represent important steps
toward bridging this gap, although the lengthy backlog of historic
medications along with 20–30 new medications approved yearly
present a daunting challenge.10 In the setting of ongoing research
and rapidly emerging literature, access to a multidisciplinary network of experts in pediatric infectious diseases is clearly essential to
optimal antimicrobial stewardship.
The activity of pharmacists relative to other health professionals on
the listserv is not surprising. In a recent survey of SHARPS
Collaborative hospitals, pharmacists had the most time devoted to
the ASP as defined by full-time equivalents (FTEs).3 Interestingly,
the participation of physicians in the listserv (1 physician e-mail for
every 2 pharmacist e-mails) exceeds the ratio of FTEs at SHARPS
Collaborative hospitals (1 physician FTE for every 3 pharmacist
FTEs). Essential synergy exists between these 2 specialties in clinical
practice and is illustrated by the active discourse on this listserv.
This study has several limitations. The number of responses may
be underestimated; we were unable to track direct communication
between listserv members outside the e-mail thread. Several members of the research teams were also members of the listserv from its
inception; we found the input of these team members vital to ensuring that the experience of the listserv was appropriately captured by
the objective classifications utilized in this study; however, their perspectives represent a potential source of bias.
Despite these limitations, this study demonstrates the importance of this platform for interprofessional support and
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dissemination of critical information among healthcare professionals navigating the challenging field of pediatric antimicrobial stewardship. Similar tools may be considered for therapeutic and
operational questions in diverse highly specialized areas of health
care. This study also highlights important gaps in knowledge in
pediatric antimicrobial therapy, and analyses like this one could represent an important tool for vetting future educational, policy, and
research efforts. Clearly, ongoing challenges include both generation
and dissemination of pertinent data to groups of healthcare
professionals, and the online community described in this report
represents one of many essential pathways.
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